Although CHTF18 and KMT5C have not been shown to correlate with RCC, they played a role in the development of other tumors; abnormalities in CHTF18 promoted endometrial carcinoma, and KMT5C played a role in non-small cell lung cancer [45, 46]. Here, CHTF18 is linked to renal cell carcinoma.